The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is having a great month on the ASX.

The company’s stock was seemingly boosted significantly by its financial year 2021 earnings and has managed to hold onto its gains.

Right now, the Clinuvel share price is $41.05, having gained 50.7% since this time last month and 0.8% since its previous close.

Let’s take a closer look at what Clinuvel reported within its financial year 2021 results.

What’s been driving Clinuvel on the ASX lately?

The Clinuvel share price has been performing exceptionally well since it released its annual results for financial year 2021.

Over the financial year just been, Clinuvel received a record $48.5 million of revenue and $24.7 million of profit after tax.

That represents respective increases of 43% and 63% on those of the previous financial year.

Clinuvel also announced a 2.5 cent dividend, in line with its dividend from the previous financial year. Though, Clinuvel’s dividends have historically been unfranked.

Over the 12 months ended 30 June 2021, Clinvuel implemented a long-term strategy for the development and commercialisation of its novel drug technology.

It also outlined its plans to increase its operations in countries including the US, Israel, and those in Europe in its results.

On the day it released its financial year 2021 earnings, the Clinuvel share price gained just 3.1%. However, it gained another 38.3% over the following 6 sessions.

Clinuvel share price snapshot

The Clinuvel share price’s recent 50% gain has added to its strong performance on the ASX.

Right now, Clinuvel’s stock is 80% higher than it was at the start of this year. It is also trading for 74% more than it was this time last year.

At its current share price, the company has a market capitalisation of around $2 billion. It has approximately 49 million shares outstanding.

The post Why the Clinuvel (ASX:CUV) share price has rocketed 50% in a month appeared first on The Motley Fool Australia.

More reading

• ASX 200 Weekly Wrap: ASX puts earnings season to bed with another rise
• These were the best performing ASX 200 shares last week
• These were the best performing ASX 200 shares in August
• ASX 200 midday update: Harvey Norman’s record profit, PointsBet posts large loss
• ASX 200 Weekly Wrap: A mixed bag of earnings dominates ASX

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3zeSkyy

The S&P/ASX 300 Index (ASX: XKO) is charging higher today following a mixed daily movement throughout the week.

At the time of writing, the ASX 300 is up 0.74% to 7,477 points. This means that over the past month, the index is now hovering around 2% lower.

Let’s take a look at which ASX companies are making headlines so far today.

Chalice Mining Ltd (ASX: CHN)

The Chalice share price is currently topping the charts, surging 9.62% to $8.09 during early afternoon trade.

Despite no recent news coming out of the mineral explorer, investors appear to be bullish on its future prospects. 

The company is focused on advancing its strategic deposit of critical, ‘green metals’ at the Julimar discovery in Western Australia.

Imugene Limited (ASX: IMU)

Another big mover on the ASX 300 is Imugene — its share price is currently up 6.10% to 43.5 cents.

The Australian immuno-oncology focused biopharmaceutical company also hasn’t released any market-sensitive news to the ASX.

However, its shares are being added to the ASX 300 Index. This enables fund managers to include Imugene shares when investing in the S&P/ASX Indices. The official date for the inclusion is 20 September.

Australian Strategic Materials Ltd (ASX: ASM)

The Australian Strategic Materials share price is pushing 4.81% higher to $10.90.

The company released its full statutory accounts yesterday, providing detailed information about its activities throughout the year.

And the companies in decline?

Lifestyle Communities Limited (ASX: LIC)

The worst performer on the ASX 300 at the time of writing is Lifestyle Communities, with its share price down 9.86% to $19.94.

According to its latest release, the company’s co-founder and managing director James Kelly offloaded a sizeable number of shares.

In total, 2 million fully paid ordinary shares were disposed of at a price of $21.50 apiece. Mr Kelly still holds around 7.1 million shares, a 6.8% stake in Lifestyle Communities.

Vulcan Energy Resources Ltd (ASX: VUL)

Lastly, the Vulcan share price has plummeted 7.67% to $14.68 on Thursday.

The lithium company announced a capital raise this morning after its shares were placed in a trading halt on Tuesday before market open.

Vulcan shares are still up roughly 1,500% over the past 12 months following strong investor sentiment in the company.

The post Which ASX shares are leading the way on the ASX 300? appeared first on The Motley Fool Australia.

More reading

• Why the Vulcan (ASX:VUL) share price is crashing 10% today
• Which ASX 300 shares are on the move mid-week?
• Which ASX 300 shares are the biggest winners and losers today?
• Here’s why the Vulcan (ASX:VUL) share price is frozen
• The Australian Strategic Materials (ASX:ASM) share price is sliding 7% on Monday

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3Ckj4zo

The Commonwealth Bank of Australia (ASX: CBA) share price is up 1% at time of writing.

That’s largely in line with the 0.8% gain currently posted by the S&P/ASX 200 Index (ASX: XJO).

With just over a month having passed since the big 4 bank released its full 2021 financial year results (FY21), we take a look at how the CBA share price has been performing since.

But first, a snapshot of those results…

What FY21 results did the big 4 bank report?

CommBank reported its FY21 results on 11 August. The CBA share price closed the previous day at $106.56.

Some core metrics included a net profit after tax (NPAT) of $8.84 billion. That was up 19.7% from the NPAT reported for FY20.

The bank also declared a final, fully franked dividend of $2 per share. CommBank’s full year dividend of $3.50 per share was up 17% from FY20.

CBA’s share price was also scrutinised after the bank announced a $6 billion off-market share buy-back.

Commenting on the share buy-back, CommBank’s CEO, Matt Comyn said:

Strategic divestments have generated $6.2 billion in excess capital since 2018. Today we have announced an off-market buy-back of up to $6 billion of CBA shares as the most efficient and appropriate way to commence the return of surplus capital, as shareholders will benefit from a lower share count that will support return on equity and dividends per share.

How has the CBA share price performed since reporting results?

The CBA share price gained 1.5% on the day the bank reported its results, closing at $108.17.

Since market open on the day of reporting, CommBank’s shares are down 3.8%. By comparison, over that same period, the ASX 200 has lost 1.1%.

At the current share price, the bank pays a trailing dividend yield of 3.4%.

With a market cap of approximately $180 billion, CommBank is the biggest of the big-4 Aussie banks.

The post How has the CBA (ASX:CBA) share price performed since reporting results? appeared first on The Motley Fool Australia.

More reading

• Could liar loans crash the housing market?
• How these 4 ASX 200 bank shares have performed since reporting results
• CBA (ASX:CBA) share price slides amid upbeat $2b loan scheme
• CBA (ASX:CBA) share price edging higher as bank supports green loans
• The CBA (ASX:CBA) share price is underperforming its big four peers today

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3EiCQgR

The BHP Group Limited (ASX: BHP) share price is on the rise in early afternoon trade today. It is currently up 1.65% to $40.92 per share.

The S&P/ASX 200 Index (ASX: XJO) is up a more modest 0.82%.

Investors will welcome the BHP share price lift today. The miner has been heavily sold off in recent weeks amid plummeting iron ore prices.

Iron ore dropped another 4% overnight to US$117 per tonne. Just 4 weeks ago, on 17 August, it was trading for US$167 per tonne. That’s 30% above today’s price.

That was also the day that BHP released its full-year 2021 financial results (FY21).

Below we recap those results, and how the BHP share price has been performing since.

What FY21 results did the ASX 200 miner report?

BHP reported its FY21 results after market close on 17 August. At the time the BHP share price stood at $51.33.

Among the key metrics BHP reported were underlying earnings before interest, taxes, depreciation, and amortisation (EBITDA) of US$37.4 billion (AU$51.2 billion). That was up 69% from FY20.

The mining giant also gifted investors a big dividend boost. The company declared a final dividend of US$2.00 per share, fully franked. That brought BHP’s full-year dividend to $3.01 per share, up 151% on the previous year.

Earnings reporting day also came with a big announcement on BHP’s merger deal with Woodside Petroleum Limited (ASX: WPL).

Commenting on the merger, BHP’s chairman Ken MacKenzie said:

The agreement to pursue a merger of BHP’s petroleum business with Woodside will maximise the value of our oil and gas assets through increased operating scale and synergies, with a more diversified product portfolio to support the energy transition.

How has the BHP share price performed since the results?

Despite the big dividend payout and soaring profits, investors hit the sell button on 18 August, the first day of trading after the results announcement. The BHP share price closed the day down a painful 7%.

Since reporting, and facing hefty tailwinds from falling iron ore prices, BHP’s shares have lost 21%.

The post How has the BHP (ASX:BHP) share price performed since reporting results? appeared first on The Motley Fool Australia.

More reading

• ASX 200 resources giants lift despite plummeting iron ore price
• 2 ASX 200 blue chip shares analysts rate as buys
• Why AGL, BHP, IRESS, & Lendlease shares are dropping
• BHP (ASX:BHP) share price slips despite potash update
• ASX 200 midday update: Pilbara Minerals jumps, bank shares fall

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3zfJznN

The Afterpay Ltd (ASX: APT) share price is struggling lately despite no price sensitive news of the company having been released to the ASX.

However, yesterday Afterpay announced a new partnership with speciality retailer PetSmart. Additionally, Afterpay was a presenting partner at New York’s Fashion Week (NYFW), running events from 7 September to 12 September.

Despite the exciting happenings, the Afterpay share price has slid 8.63% so far this month. It is currently trading at $122.85.

Let’s take a closer look at what the buy now, pay later (BNPL) company has been up to, and what it’s planning to do next.

September so far for Afterpay

September hasn’t been a good month so far for the Afterpay share price despite several pieces of seemingly positive non-price sensitive news.

Yesterday, Afterpay announced it has partnered with pet retailer PetSmart. The partnership will see PetSmart offering its customers to pay for products and services using Afterpay.

According to Afterpay, PetSmart is the largest retailer of its kind and the first to offer Afterpay’s BNPL service.

In addition to its new partnership, Afterpay ran a series of interactive events at NYFW.  

Afterpay offered pop-up and virtual reality shopping experiences, insider talks and styling workshops, a virtual catwalk from which shoppers could purchase items, and turned the Empire State Building into its signature shade of blue-green.

Fun fact: Afterpay’s trademark colour is named Bondi Mint.

However, the glitz and glamour weren’t enough to save the Afterpay share price.

What’s next for Afterpay and its share price?

The Afterpay share price might not exist for much longer.

As market watchers will know, the company is planning to be acquired by Square Inc (NYSE: SQ) in a $39 billion takeover.

The companies expect the takeover to go ahead in the current quarter. It is still subject to shareholder approval.

Of course, following the takeover Afterpay won’t exist on the ASX anymore. However, as the takeover is expected to be a scrip deal, Square will be listing CHESS Depository Interests (CDIs) on the ASX.

Meaning, Afterpay’s shareholders who receive CDIs will still be able to trade their holdings on the ASX. Though, Afterpay shareholders will be able to elect to receive NYSE-listed Square shares instead.

Additionally, Afterpay announced some of its future plans within its results for the financial year just been.

As The Motley Fool Australia reported at the time, Afterpay believes Germany is a “priority region” for expansion. It is also looking to increase its footprint in Singapore.

The post The Afterpay (ASX:APT) share price is down 9% in September. What’s next? appeared first on The Motley Fool Australia.

More reading

• Why I’m holding my Afterpay (ASX:APT) shares: expert
• 2 ASX shares ready to explode after COVID: expert
• Why Afterpay, Chorus, NAB, & Omni Bridgeway shares are dropping
• ASX 200 tech shares are dragging the market on Monday
• Afterpay (ASX:APT) shares are up 900% since the crash. These experts still think they’re worth holding

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended AFTERPAY T FPO and Square. The Motley Fool Australia owns shares of and has recommended AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3CfS5oL

The Novonix Ltd (ASX: NVX) share price is having an uncharacteristically bad week.

In afternoon trade on Thursday, the battery materials company’s shares are down almost 2% to $5.59.

This means the Novonix share price has now pulled back by almost 9% since peaking at $6.12 on Friday.

What’s going on with the Novonix share price?

The Novonix share price came off the boil this week after a leading broker called time on its incredible rally.

And what a rally it has been. When the company’s shares hit $6.12 on Friday, it meant they were up a staggering ~400% since the start of the year.

This has been driven by increasingly bullish sentiment in the battery materials sector, news of a strategic investment by US energy giant Phillips 66, and its inclusion in the ASX 300 index.

However, as positive as this all is, the team at Morgans believe it is all priced into the Novonix share price now.

What did the broker say?

According to the note, the broker has downgraded the company’s shares to a hold rating with an improved price target of $5.68. This is broadly in line with where the Novonix share price trades now.

Morgans explained: “NVX’s prospects continue to look promising however we think the share price already reflects a lot of the future success that we think the company will achieve. There is still a small premium to our updated base case valuation but we think the risk to reward is less attractive than before. We therefore reduce our rating to HOLD as we wait for more detail on the company’s progress on the Samsung quality audit and confirmation of our expectations for gross margins.”

In light of this, Morgans appears to believe investors should wait for a better entry point before buying shares.

The post The Novonix (ASX:NVX) share price appears to have come off the boil. Is it a buy? appeared first on The Motley Fool Australia.

More reading

• Why Australian Ethical, Brambles, Novonix, & Zip shares are tumbling lower
• Novonix (ASX:NVX) share price falls on broker downgrade
• Why Centaurus Metals, IGO, Novonix, Rhinomed shares are storming higher
• Which ASX 300 shares are leading the way as the top movers on Friday?
• Novonix (ASX:NVX) share price surges again to record high, up 11% this week

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3kcOd1v

The Medibank Private Ltd (ASX: MPL) share price has been struggling lately.

Since reaching a 52-week high of $3.62 a share back on 7 September, the Medibank share price has fallen by more than 2% to sit at $3.55 a share so far today.

Even so, the company remains up by 16.6% year to date, and up a very healthy 38.3% over the past 12 months.

But why have Medibank shares been struggling over the past week or two?

Medibank share price struggles after ex-dividend date

Well, one anchor on the Medibank share price last week was its ex-dividend date.

In Medibank’s FY21 earnings report, which it delivered last month, the company announced a final dividend for FY21 of 6.9 cents per share, fully franked.

That payment will hit investors’ pockets on 30 September. But it left the Medibank share price on 8 September when the shares went ex-dividend.

This is the primary reason why the Medibank share price has struggled ever since.

Even so, shareholders might not be too concerned. This final dividend was a boost from FY20’s final payout of 6.3 cents per share.

Another potential reason for Medibank’s recent struggle is some private health sector news.

According to a report on news.com.au this week, private health insurers like Medibank have been offering their customers ‘COVID discounts’.

The report states that “some of the largest insurers [are handing] back funds collected in premiums that didn’t get paid in claims due to Covid restrictions”.

This includes Medibank, which the report states has “also committed to returning around $105 million in Covid-19 net claims through premium relief for Australian Medibank and ahm customers with an active hospital and/or extras policy between the 2020/21 financial year”.

Whilst this news may please Medibank’s customers, it is still unquestionably deleterious to the company’s overall finances. This may have been deterring investors in recent times.

At the current Medibank Private share price of $3.55, the company has a market capitalisation of $9.78 billion. It also has a price-to-earnings (P/E) ratio of 22.16 and a dividend yield of 3.58%

The post Why is the Medibank (ASX:MPL) share price struggling lately? appeared first on The Motley Fool Australia.

More reading

• Why A2 Milk, Flight Centre, Medibank, & St Barbara shares are dropping
• Dividends galore! 10 ASX shares trading ex-dividend on Wednesday
• 5 things to watch on the ASX 200 on Wednesday
• Here’s why the Medibank (ASX:MPL) share price jumped 7% in a month
• How does the Medibank (ASX:MPL) earnings result compare to NIB?

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3tGYpCM

The Whitehaven Coal Ltd (ASX: WHC) share price has stepped into the green on Thursday.

At one stage Whitehaven shares were as high as $3.18. They have since partially retreated and at the time of writing are swapping hands for $3.11 apiece. That’s a rise of 2.98% on the day.

Whitehaven shares are on the move after the company gained regulatory approval for a controversial coal expansion project that’s been on the slab since July.

There’s a lot of moving parts here – but don’t worry, we’ve done the analysis for you.

What was announced today?

Whitehaven Coal advised that controversial plans to extend open-cut operations at its Vickery metallurgical coal project in New South Wales have now been approved.

The company announced that Federal Minister for the Environment, Susan Ley, had awarded environmental consent for the coal giant to proceed with its $600 million extension plans.

The extension project was approved under the Commonwealth’s Environment Protection and Biodiversity Conservation Act 1999, as per the release.

Back in July, a Federal Court ordered the government to assess the potential harm young people could face from additional carbonisation as a result of the expansion, before approving Whitehaven’s plans.

However, Ley’s ruling will ensure annual coal extraction will more than double to around 10 million tonnes at the Vickery project.

Whitehaven “welcomed” the decision, which it stated was the “culmination of an exhaustive process” that took more than 5 years.

This included a “period of public exhibition” from the NSW government. During this, 62% of the public submissions called for the project’s approval due to the “substantial local economic benefits” on offer.

Whitehaven sees a “continuing role” for the high-quality coal that Vickery can produce. This is against a background of “record high coal prices and strong demand in seaborne markets”.

“Major employment-generating investments will be essential” as Australia navigates its way out of the COVID-19 pandemic, Whitehaven concluded.

Investors appear to agree with this sentiment and have pushed the Whitehaven Coal share price 3% higher following the release.

Whitehaven Coal share price snapshot

The Whitehaven Coal share price has gained steam over the last few months.

It has posted a year-to-date return of 87%. It is also up 238% over the past 12 months. That’s well ahead of the S&P/ASX 200 index (ASX: XJO)’s gain of around 25% over the same time.

The post Here’s why the Whitehaven Coal (ASX:WHC) share price is rising today appeared first on The Motley Fool Australia.

More reading

• Here are 2 ASX mining shares up 25% in the past month
• Why the Whitehaven (ASX:WHC) share price is gaining on Friday
• Here are the 3 most heavily traded ASX 200 shares today
• Whitehaven Coal (ASX:WHC) share price hits 52-week highs. Here’s why
• ASX 200 energy shares in firing line of United Nations’ climate action

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3hCESyl

The Coles Group Ltd (ASX: COL) share price is pushing higher on Thursday afternoon.

At the time of writing, the supermarket giant’s shares are up almost 1% to $17.15.

This means Coles’ shares have now reduced their year to date decline to approximately 7%.

Is the Coles share price good value?

While the weakness in the Coles share price this year is disappointing for shareholders, it could be a buying opportunity for non-shareholders.

According to a recent note out of Morgans, its analysts have an add rating and $19.80 price target on the company’s shares.

Based on the current Coles share price, this suggests there is 15% upside over the next 12 months before dividends.

And if we include dividends, the potential return gets even more attractive. Morgans is forecasting a fully franked 61 cents per share dividend in FY 2022. Including this, the company’s shares could provide a total return of 19% between now and this time next year.

What did the broker say?

Morgans was pleased with the company’s performance in FY 2021 and also with its solid start to the new financial year. This led the broker to upgrading its forecasts for FY 2022 and its price target on the Coles share price accordingly.

In addition to this, its analysts like Coles due to its defensive qualities, strong market position, and robust balance sheet.

The broker commented: “Following the better-than-expected FY21 result, we increase FY22F EBIT by 2% to A$1,852m while underlying NPAT rises by 4% to A$996m. COL is a defensive business with strong market positions and a healthy balance sheet. Trading on 24.6x FY22F PE and 3.3% yield we continue to see the stock as offering good value and maintain our Add rating.”

The post Why this broker sees the Coles (ASX:COL) share price rising 15% appeared first on The Motley Fool Australia.

More reading

• 2 buy-rated ASX dividend shares with attractive yields
• How does the Wesfarmers (ASX:WES) dividend compare to Woolworths?
• Why this analyst sees 15% upside for the Coles (ASX:COL) share price
• Coles (ASX:COL) share price on watch amid latest push to Kmart market
• 4 ASX shares just got a massive boost

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended COLESGROUP DEF SET. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3tRJgP1

Shares in Healthia Ltd (ASX: HLA) are surging today after the health-based company announced a new acquisition.

At the time of writing, the Healthia share price is travelling north of 10% to $1.98 apiece.

Healthia expands business portfolio

Investors are fighting to get a hold of Healthia shares following the company’s latest addition to its growing portfolio.

According to the release, Healthia advised it has entered into a binding agreement to acquire Rothwell Physiotherapy.

A family-owned and operated clinic, Rothwell Physiotherapy is located on the north side of Brisbane. The facility, which services the wider Moreton Bay region, provides physiotherapy and exercise physiology for patients.

The upfront consideration for Rothwell Physiotherapy will be a cash payment of $1.3 million. In addition, a contingent consideration of $0.32 million will be available if pre-defined earnings targets are achieved.

The settlement of Rothwell Physiotherapy is conditional upon the transfer of property leases to Healthia and the approval of usual customary conditions.

It’s expected that all conditions will be met and the acquisition completed on or before 30 November 2021.

Management commentary

Healthia managing director Wesley Coote said:

We are very much looking forward to welcoming the team at Rothwell Physiotherapy into the Healthia family. The addition of Rothwell Physiotherapy is in line with Healthia’s stated growth strategy, and brings us one step closer to being the number one provider of physiotherapy services in Australia.

We have a strong acquisition pipeline in place for this financial year, underpinned by industry participants placing greater value on the support and stability that a larger group such as Healthia, can provide.

The company has projected the acquisition would contribute additional revenue of $2.13 million to Healthia. Furthermore, it estimates earnings before interest, tax, depreciation and amortisation (EBITDA) to come in around $0.36 million.

Healthia share price summary

Since listing on the ASX in September 2018, Healthia has grown its portfolio from 104 to 217 allied health businesses. Recent acquisitions include AllCare Physiotherapy, John Holme Optometry and Anytime Physio.

The company’s shares are up 50% in 2021, and have more than doubled over the past 12 months.

The post Why the Healthia (ASX:HLA) share price is rocketing 10% today appeared first on The Motley Fool Australia.

More reading

• Why the Austal (ASX:ASB) share price is lifting today
• Wesfarmers (ASX:WES) share price edges higher on sweetened API bid
• ASX 200 resources giants lift despite plummeting iron ore price
• Lotus Resources (ASX:LOT) share price jumps on rare earths update
• ASX uranium shares boom to multi-year highs, bull market is just getting started: analyst

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended HEALTHIA FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3ltUg1h